| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEOGENOMICS INC | President, Clinical Services | Common Stock | 43,216 | $794,742 | $18.39 | 01 Aug 2022 | Direct |
| Invitae Corp | Chief Operating Officer | Common Stock | 850,000 | $550,800 | $0.6480 | 13 Nov 2023 | Direct |
| NEOGENOMICS INC | President, Clinical Services | Stock Option (Right to Buy) | 25,826 | 01 Aug 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017023063939-sholehvar-david-2023-11-13 | Invitae Corp | 13 Nov 2023 | 1 | $0 | 4 | Chief Operating Officer | 14 Nov 2023, 19:58 |
| /report/000095017023063938-sholehvar-david-2023-11-13 | Invitae Corp | 13 Nov 2023 | 0 | $0 | 3 | Chief Operating Officer | 14 Nov 2023, 19:55 |
| NEO | NEOGENOMICS INC | 01 Aug 2022 | 2 | $0 | 4 | President, Clinical Services | 03 Aug 2022, 17:45 |
| NEO | NEOGENOMICS INC | 01 Apr 2022 | 2 | $0 | 4 | President, Clinical Services | 04 Apr 2022, 19:07 |
| NEO | NEOGENOMICS INC | 14 Mar 2022 | 0 | $0 | 3 | President, Clinical Services | 21 Mar 2022, 16:25 |